390 related articles for article (PubMed ID: 18220790)
1. Editorial: Angiogenesis agents.
Marcinkiewicz C
Curr Pharm Des; 2007; 13(35):3543-4. PubMed ID: 18220790
[No Abstract] [Full Text] [Related]
2. Angiogenesis: molecular mechanisms of activation, promotion and maintenance.
Bikfalvi A
J BUON; 2007 Sep; 12 Suppl 1():S59-66. PubMed ID: 17935279
[TBL] [Abstract][Full Text] [Related]
3. Identification of novel drug targets for angiostatic cancer therapy; it takes two to tango.
Thijssen VL; van Beijnum JR; Mayo KH; Griffioen AW
Curr Pharm Des; 2007; 13(35):3576-83. PubMed ID: 18220794
[TBL] [Abstract][Full Text] [Related]
4. Reversal of cellular roles in angiogenesis: implications for anti-angiogenic therapy.
Virgintino D; Ozerdem U; Girolamo F; Roncali L; Stallcup WB; Perris R
J Vasc Res; 2008; 45(2):129-31. PubMed ID: 17943023
[No Abstract] [Full Text] [Related]
5. Written in the blood.
Lewis R
Nature; 2006 Mar; 440(7084):710-1. PubMed ID: 16637100
[No Abstract] [Full Text] [Related]
6. Is angiogenesis an organizing principle in biology and medicine?
Folkman J
J Pediatr Surg; 2007 Jan; 42(1):1-11. PubMed ID: 17208533
[No Abstract] [Full Text] [Related]
7. CD36-TSP-HRGP interactions in the regulation of angiogenesis.
Silverstein RL; Febbraio M
Curr Pharm Des; 2007; 13(35):3559-67. PubMed ID: 18220792
[TBL] [Abstract][Full Text] [Related]
8. Nanoparticulate drugs for the manipulation of angiogenesis.
Millar TM; Kanaras AG
Ther Deliv; 2013 Oct; 4(10):1217-9. PubMed ID: 24116904
[No Abstract] [Full Text] [Related]
9. Current insights on the biology and clinical aspects of VEGF regulation.
Birk DM; Barbato J; Mureebe L; Chaer RA
Vasc Endovascular Surg; 2008 Dec-2009 Jan; 42(6):517-30. PubMed ID: 18799497
[TBL] [Abstract][Full Text] [Related]
10. In vitro assays of angiogenesis for assessment of angiogenic and anti-angiogenic agents.
Goodwin AM
Microvasc Res; 2007; 74(2-3):172-83. PubMed ID: 17631914
[TBL] [Abstract][Full Text] [Related]
11. Dimethylarginine dimethylaminohydrolase: a new therapeutic target for the modulation of nitric oxide and angiogenesis.
Singh JP
Curr Opin Investig Drugs; 2007 Sep; 8(9):736-41. PubMed ID: 17729185
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of angiogenesis and remodelling of the microvasculature.
Silvestre JS; Lévy BI; Tedgui A
Cardiovasc Res; 2008 May; 78(2):201-2. PubMed ID: 18339645
[No Abstract] [Full Text] [Related]
13. Angiogenesis--a new target for future therapy.
Pandya NM; Dhalla NS; Santani DD
Vascul Pharmacol; 2006 May; 44(5):265-74. PubMed ID: 16545987
[TBL] [Abstract][Full Text] [Related]
14. Modified fibrin hydrogel matrices: both, 3D-scaffolds and local and controlled release systems to stimulate angiogenesis.
Hall H
Curr Pharm Des; 2007; 13(35):3597-607. PubMed ID: 18220797
[TBL] [Abstract][Full Text] [Related]
15. Angiogenesis blockade as therapy for hepatocellular carcinoma: progress and challenges.
Hao CY
J Gastroenterol Hepatol; 2011 Jan; 26(1):4-6. PubMed ID: 21175786
[No Abstract] [Full Text] [Related]
16. Angiogenesis inhibitors: what is the clinical future?
Verheul HM; Pinedo HM
Prog Drug Res; 2005; 63():67-91. PubMed ID: 16265877
[No Abstract] [Full Text] [Related]
17. Angiogenesis inhibitors in the treatment of prostate cancer.
Adesunloye BA; Karzai FH; Dahut WL
Chem Immunol Allergy; 2014; 99():197-215. PubMed ID: 24217611
[TBL] [Abstract][Full Text] [Related]
18. History of research on angiogenesis.
Ribatti D
Chem Immunol Allergy; 2014; 99():1-14. PubMed ID: 24217600
[TBL] [Abstract][Full Text] [Related]
19. Targeting angiogenic metabolism in disease.
Li X; Carmeliet P
Science; 2018 Mar; 359(6382):1335-1336. PubMed ID: 29567696
[No Abstract] [Full Text] [Related]
20. Paradoxic effects of metformin on endothelial cells and angiogenesis.
Dallaglio K; Bruno A; Cantelmo AR; Esposito AI; Ruggiero L; Orecchioni S; Calleri A; Bertolini F; Pfeffer U; Noonan DM; Albini A
Carcinogenesis; 2014 May; 35(5):1055-66. PubMed ID: 24419232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
